KNSL icon

Kinsale Capital Group

491.66 USD
+3.93
0.81%
At close Apr 23, 4:00 PM EDT
Pre-market
491.99
+0.33
0.07%
1 day
0.81%
5 days
1.28%
1 month
1.86%
3 months
13.60%
6 months
7.21%
Year to date
8.29%
1 year
5.88%
5 years
364.27%
10 years
2,579.35%
 

About: Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

Employees: 674

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

109% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 44

22% more repeat investments, than reductions

Existing positions increased: 218 | Existing positions reduced: 179

12% more capital invested

Capital invested by funds: $9.08B [Q3] → $10.2B (+$1.08B) [Q4]

8% more funds holding

Funds holding: 528 [Q3] → 569 (+41) [Q4]

1.26% more ownership

Funds ownership: 84.01% [Q3] → 85.27% (+1.26%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 8 [Q3] → 8 (+0) [Q4]

5% less call options, than puts

Call options by funds: $34.6M | Put options by funds: $36.5M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$500
2%
upside
Avg. target
$515
5%
upside
High target
$525
7%
upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Truist Securities
Mark Hughes
57% 1-year accuracy
35 / 61 met price target
7%upside
$525
Buy
Maintained
18 Feb 2025
RBC Capital
Scott Heleniak
68% 1-year accuracy
30 / 44 met price target
2%upside
$500
Sector Perform
Reiterated
18 Feb 2025
Morgan Stanley
Bob Huang
72% 1-year accuracy
13 / 18 met price target
6%upside
$520
Overweight
Maintained
14 Feb 2025

Financial journalist opinion

Based on 14 articles about KNSL published over the past 30 days

Positive
Zacks Investment Research
2 days ago
KINS vs. KNSL: Which Excess & Surplus Insurer Should You Bet On?
Let's find out which insurer is a safe investment option, KINS or KNSL.
KINS vs. KNSL: Which Excess & Surplus Insurer Should You Bet On?
Positive
Seeking Alpha
4 days ago
Our Top 10 High Growth Dividend Stocks - April 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
Our Top 10 High Growth Dividend Stocks - April 2025
Positive
Zacks Investment Research
5 days ago
Gear Up for Kinsale Capital Group (KNSL) Q1 Earnings: Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Kinsale Capital Group (KNSL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Gear Up for Kinsale Capital Group (KNSL) Q1 Earnings: Wall Street Estimates for Key Metrics
Positive
The Motley Fool
6 days ago
Kinsale Capital: A High Performer in Specialty Insurance
Explore the exciting world of Kinsale Capital (KNSL 0.65%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Kinsale Capital: A High Performer in Specialty Insurance
Negative
Zacks Investment Research
6 days ago
Analysts Estimate Kinsale Capital Group, Inc. (KNSL) to Report a Decline in Earnings: What to Look Out for
Kinsale Capital Group (KNSL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Kinsale Capital Group, Inc. (KNSL) to Report a Decline in Earnings: What to Look Out for
Neutral
Zacks Investment Research
1 week ago
SKWD vs. KNSL: Which Stock Is the Better Value Option?
Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Skyward Specialty Insurance (SKWD) and Kinsale Capital Group, Inc. (KNSL). But which of these two stocks presents investors with the better value opportunity right now?
SKWD vs. KNSL: Which Stock Is the Better Value Option?
Positive
Zacks Investment Research
1 week ago
Why the Market Dipped But Kinsale Capital Group, Inc. (KNSL) Gained Today
In the closing of the recent trading day, Kinsale Capital Group, Inc. (KNSL) stood at $478.23, denoting a +1.46% change from the preceding trading day.
Why the Market Dipped But Kinsale Capital Group, Inc. (KNSL) Gained Today
Negative
Zacks Investment Research
2 weeks ago
Kinsale Capital Group, Inc. (KNSL) Increases Despite Market Slip: Here's What You Need to Know
Kinsale Capital Group, Inc. (KNSL) closed the most recent trading day at $498.60, moving +1.44% from the previous trading session.
Kinsale Capital Group, Inc. (KNSL) Increases Despite Market Slip: Here's What You Need to Know
Neutral
Business Wire
2 weeks ago
Kinsale Capital Group Announces First Quarter 2025 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Kinsale Capital Group Announces First Quarter 2025 Earnings Release Date and Conference Call.
Kinsale Capital Group Announces First Quarter 2025 Earnings Release Date and Conference Call
Neutral
CNBC Television
2 weeks ago
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group.
Final Trades: Amgen, Sabra Health Care and Kinsale Capital Group
Charts implemented using Lightweight Charts™